ERYTECH Pharma S.A. (ERYP) Q3 2022 Earnings Call Transcript

Nov. 22, 2022 10:24 AM ETERYTECH Pharma S.A. (ERYP), ERYFF
SA Transcripts profile picture
SA Transcripts

ERYTECH Pharma S.A. (NASDAQ:ERYP) Q3 2022 Earnings Conference Call November 22, 2022 8:30 AM ET

Company Participants

Gil Beyen - CEO

Eric Soyer - CFO and COO

Conference Call Participants

Boris Peaker - Cowen


Good morning, and thank you for standing by. Welcome to the ERYTECH Business Update and Financial Highlights for the Third Quarter of Year 2022. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to turn the conference over to your speaker today, Gil Beyen CEO of ERYTECH. Please go ahead.

Gil Beyen

Thank you. Good afternoon, good morning. Bonjour a tous. Thank you for joining us for our business and financial update call to discuss the business highlights for the third quarter of 2022 and the financials for the first nine months of this year. We announced our business and financial update yesterday evening, and the press release and the webcast presentation can be found on the Investor Relations page of our website.

Turning to Slide 2, before starting as usual, I have to draw your attention to the disclaimer to remind you that today's call includes forward-looking statements. And as you know, they all involve risks and uncertainties that could cause actual timings and results to differ materially.

Slide 3, the agenda. Joining me on the call today are Dr. Iman El-Hariry our Chief Medical Officer, and Eric Soyer, our Chief Financial and Chief Operating Officer. I will start with a short introduction and present the key business highlights of the year-to-date, focusing on the more recent ones, the ones that occurred after our last call in September. After which, Eric will present an update on our key financials and cash balance, he will also summarize the expected milestones

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.